Investing

Centessa Pharmaceuticals : CNTA

CNTA

Stock Data

$39.57

$0.15 (0.38%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Centessa Pharmaceuticals plc is a pioneering clinical-stage pharmaceutical company focused on creating innovative medicines. With a diverse pipeline, including treatments for hemophilia, sleep disorders, autoimmune diseases, and pulmonary arterial hypertension, Centessa aims to address complex medical challenges. Key projects include SerpinPC for hemophilia, ORX750 for sleep disorders, and LB101 for enhancing immune response, among others. Founded in 2020 and based in the UK, Centessa is dedicated to advancing healthcare through scientific discovery and development.

All Centessa Pharmaceuticals Articles

2 Articles

Lee Jackson | Apr 13, 2026 at 6:50 AM EDT

Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Best Buy, Bilibili, Constellation Brands, CoreWeave, Nike, Starbucks, T-Mobile, and More

Pre-Market Stock Futures: Futures are trading lower this morning after negotiations with Iran failed over the weekend, and President Trump…

Lee Jackson | Apr 1, 2026 at 8:02 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More

Pre-Market Stock Futures: Futures are trading higher after an explosive rally on Tuesday, sparked by the President’s comments that he…